Brief: Egetis Therapeutics Gets Medicine Designation In UK For Emcitate®

Egetis Therapeutics AB (publ)

03/06/2024 06:12

June 3 (Reuters) - Egetis Therapeutics AB (publ)
 EGTX.ST :
    * AWARDED PROMISING INNOVATIVE MEDICINE DESIGNATION IN UK
FOR
EMCITATE® (TIRATRICOL) FOR TREATMENT OF MCT8 DEFICIENCY

Source text for Eikon:  ID:nMFN4yg5QC 
Further company coverage:  EGTX.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))